Assuming it is next step "Approval" by FDA following prelisting with "Clearance" status, expect should give medical world increased confidence and bode well for product expansion particularly in American market, which will hopefully be reflected in rerated share price. Thurs could be interesting!
Ann: Trading Halt, page-7
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
0.010(1.94%) |
Mkt cap ! $215.5M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.5¢ | 51.0¢ | $166.6K | 319.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 75731 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 18140 | 5 |
View Market Depth
| Last trade - 14.19pm 29/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |